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ABSTRACT
Has U.S. health care for the elderly become more equitable during the past several decades? When
inequality is measured by Medicare expenditures, the answer is yes. During 1987-2001, low income
households experienced an increase of 78 percent ($2624) in per capita expenditures, double the
increase of 34 percent ($1214) in the highest income group. When inequality is measured by life
expectancy, the answer is no. Survival for the lowest income decile grew by 0.2 years during the
1990s compared to 0.8 years in the highest income group. That the two measures deliver such
discordant messages may reflect their intrinsic shortcomings; expenditures depend on preferences,
health status, and prices, while outcomes are strongly affected by health behavior and past illness.
We suggest a new approach to measuring inequality:  the  use of quality-based effective care
measures. For these measures, efficacy is well proven and nearly all of the relevant population
should be receiving it, regardless of health status or preferences. Using Medicare claims data
matched to zip code income, we find greater use of mammography screening, diabetic eye exams,
and the use of ââ blockers and reperfusion following heart attacks among higher income households,
and these differences appear to be stable or growing slowly over time. In sum, the rapid relative
growth in health care expenditures among low income elderly people has not translated into relative
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weiping@dartmouth.edu   The technological revolution in health care has brought both great benefits with 
respect to survival and general well-being, and substantial increases in costs.
1  Whether 
these changes have reduced inequality in health care or in health outcomes is not well 
understood. Earlier research suggested that medical care innovations, such as the use of 
antibiotics in the treatment of tuberculosis, reduced health care disparities by race 
(McDermott, 1978).  On the other hand, studies of health care expenditures by income 
group found higher income groups accounting for a larger fraction of spending, 
particularly after accounting for health status.
2  Recent studies also suggest that better 
educated patients get access to newer drugs (Lleras-Muney and Lichtenberg, 2002), 
survive longer following the diagnosis of cancer (Glied and Lleras-Muney, 2003) and 
comply better with regimens for the treatment of AIDS (Goldman and Smith, 2002).       
This paper returns to the question of whether technological advances and 
increases in health care expenditures have been associated with a widening or a 
narrowing of inequality in health or in health care.  The group studied is the over-65 
population in the United States during the 1990s, which is of interest given their high 
rates of utilization and very high rates of insurance coverage under the Medicare 
program.  Initially, two conventional measures of inequality are considered: health care 
expenditures and health care outcomes as measured by 10-year survival rates.  Using 
                                                 
1  Cutler et. al. (1998), Cutler and McClellan (2001), Cutler (2004), Skinner, Staiger, and Fisher 
(2004). 
 
2   For the older literature, see LeGrand (1978, 1982), Le Grand et. al. (1991), Wagstaff et. al., 
(1991), Davis and Reynolds (1975), Link, Long, and Settle (1982).  More recently see McClellan 
and Skinner (2004), although see Kapur et. al. (2004), and Battacharya and Lakdawalla (2004).  
Chen and Escarce (2004) find a pronounced negative association between income and 
expenditures, but reverses the association after controlling for a host of covariates measuring 
wellbeing and disease burden.  Other studies find quite nuanced patterns, for example Gittelsohn, 
Halpern, and Sanchez (1991) and Morris, Sutton, and Gravelle (2003). 
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detailed Medicare claims data on a panel of several million people in the over-65 
population in the United States back to 1987, we matched individuals to income deciles 
based on median income in their zip code of residence.  Between 1987 and 2001, we 
found a dramatic increase in health care expenditures among the lowest income groups, 
accounting for a 78 percent increase ($2624) in real terms compared to a 34 percent 
increase ($1214) for those in the top income decile.  Using expenditures as a marker for 
health inequality, one would conclude that inequality has lessened, and if anything the 
higher (annual) expenditures for lower income households would help to compensate for 
earlier years during which insurance coverage and preventive care was minimal.
3  
There are a variety of disadvantages to using expenditures for health care as a 
measure of access, however.  Expenditures may reflect patient preferences, health status,  
and access to care, nor is it clear how expenditures on health care translate into health 
outcomes (e.g., Fisher et. al., 2003a,b).  For example, much of the differential increase in 
expenditures by income group during this period was accounted for by home health care, 
a program where 40 cents of every dollar in spending was deemed inappropriate by one 
government investigation (Havemann, 1997). 
A different picture emerges in the evolution of outcomes as measured by 10-year 
survival rates.  While each income group experienced a survival gain during the 1990s, 
those in higher income groups did better: life expectancy rose by 0.2 years in the bottom 
income decile compares to 0.8 years in the top income decile.  But this measure is not 
immune from criticism either. Individual decisions regarding healthy behavior exert an 
important influence on health outcomes over the life-course, and it is rarely clear whether 
these choices should be attributed to “preferences,” education, or economic status per se 
                                                 
3 See Decker, 2004; McWilliams, et. al., 2003; Card, Dobkin, and Maestas, 2004.   3 
(Graham, 2002; Contoyannis and Jones, 2004; Smith, 2003).   As well, long and variable 
lags in outcomes make it difficult to evaluate the impact of the current health care 
expenditures on changes in current health outcomes, particularly when income itself is 
endogenous to health status (Case and Deaton, 2003).  
That the two measures of health inequality are contradictory suggest the need for 
a different approach.  We propose focusing on a more limited set of effective (or high-
quality) utilization measures with well-established benefits.
4  These measures include 
mammography screening among women age 65-69, eye examinations for diabetics, and 
smoking cessation advice, aspirin, ￿-blockers, and reperfusion in the first 12 hours 
following the heart attack.   These latter three treatments accounted for the vast majority 
of improvement in 30-day survival following heart attacks (Heidenreich and McClellan, 
2001).  The advantage of these measures over expenditures is that one need not control 
for health status; nearly everyone in the appropriate universe should be receiving these 
treatments.  Nor does one need to control for preferences towards health care, or for 
lifestyle differences; every appropriate heart attack patient should be receiving ￿-
Blockers upon admission, regardless of whether they are marathon runners or couch 
potatoes.
5  The use of these measures are not dependent on genetic or environmental 
factors that might further confound differences in survival rates across income groups.  
As well, there is increasing effort to collect these measures as components of health care 
quality indices, for example by the National Committee for Quality Assurance (NCQA) 
at the hospital level or by Jencks (2003) at the state level.   
                                                 
4  This terminology follows that in Wennberg et. al. (2002).   
 
5  In some cases, preferences can still play a role in screening programs, see Walter et. al. (2004).  
The question is then raised as to whether those preferences against effective care reflect past 
adverse encounters with the health care system.    4 
  Using the Medicare claims data augmented with the Cooperative Cardiovascular 
Project (CCP) data for heart attack patients in 1994/95, we find distinct income gradients 
with regard to the use of effective care.  For mammography, examination rates for the top 
income decile were 16 percentage points higher than the lowest decile in 1993, and by 
2001 the gap had shrunk only slightly to 15 percentage points.  For the inpatient 
treatment of heart attacks in 1994/95, where the use of effective care is unlikely to have 
any incremental impact on patient costs and where noncompliance is minimal, the 
income gradients are smaller; 7 percentage points for ￿ blockers and 5 percentage points 
for reperfusion therapy within 12 hours, with no significant differences in aspirin or ACE 
inhibitor use.
6 
In sum, the dramatic increases in relative Medicare expenditures for low income 
neighborhoods during the past several decades have not translated into similar 
improvements in health outcomes.  The apparent lack of relative improvement in 
effective care among the lowest income groups makes this puzzle less surprising, but by 
itself cannot explain the widening of survival trends by income group.
7  Still, the use of 
effective care measures can allow the government to work towards actually doing 
something about inequality in health care.  Monitoring and rewarding providers and 
patients to raise rates near the 100 percent ideal for all Medicare enrollees would have the 
additional salutary effect of erasing inequality in the dimension of effective care.  
                                                 
6  Reperfusion therapy (12-hour surgical angioplasty or “clot busting” thrombolytics) is effective 
at removing the blockage or clots restricting blood flow to the heart.  Aspirin is effective at 
breaking down platelets that are essential components of these clots interfering with blood flow.  
ACE inhibitors attenuate the body’s natural tendency to constrict vascular walls, while ￿ blockers 
reduce the body’s demands on the heart. 
 
7 See also Baicker and Chandra (2004), who have shown this lack of association between 
Medicare expenditures and effective care measures at the regional level. 
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1.  The Measurement of Health and Health Care Inequality  
It is important to distinguish between inequality in health care and inequality in 
health.  There is a long history of measuring inequality in health care by the use of 
utilization or expenditures measures.  Le Grand (1978, 1982) and others found a positive 
gradient between expenditures and income after controlling for measures of health status 
in the United Kingdom, even after several decades of National Health Insurance.  While 
there was a lively debate about how best to measure income-based gradients in health 
care ( Wagstaff et. al., 1991, Le Grand, 1991), the positive association between 
expenditures and income has been found in many countries with just a few exceptions 
(Wagstaff et. al., 1991).  The earlier evidence from the United States pointed towards the 
same positive association between expenditures and income (Davis and Reynolds, 1975; 
Link, Long, and Settle, 1982), although more recent data on Medicare expenditures in the 
1990s suggests that lower income households have began to account for higher levels of 
spending (Lee, McClellan, and Skinner, 1999; McClellan and Skinner, 2004. 
Health care expenditures have been used to construct measures of “full income” 
that include both money income and government-financed health care expenditures.  This 
approach was pioneered by Eugene Smolensky and his colleagues at Wisconsin during 
the 1970s in the study of income distribution (Reynolds and Smolensky, 1977; Moon, 
1977), and extended to valuing health care benefits in a money-metric context 
(Smolensky, et. al., 1977).  More recently, Fuchs (1998a, 2001) has used this approach to 
document the very large fraction of full income among the elderly in the U.S. comprised 
of health care expenditures, most of which is paid for by younger generations.  The 
implicit message in creating full income measures is the opportunity cost of health care   6 
spending, that a reduction in health care spending could have a large impact on money 
income, particularly among low income groups. 
The interest in illness-adjusted expenditures or utilization can be motivated by a 
concern about access to care, where the null hypothesis of perfect equality is presumably 
one where high income and low income individuals with similar medical ailments would 
be treated with the same procedures and with the same degree of intensity.  But some 
have questioned whether equal rates of utilization are really the same as equal access, for 
example if people with high incomes experienced different preferences for care (Mooney 
et. al., 1991, Culyer et. al., 1992).  While economists are generally comfortable taking 
preferences as given, the issue is less clear in the health care literature.  For example, 
Ibrahim, et. al. (2001, 2002) documented more distrust of surgery among black 
candidates for hip or knee replacement, and placed greater reliance on alternative (non-
surgical) approaches such as copper bracelets or prayer.  Katz (2001) has distinguished 
between preferences “guided by informed decisions” and those “limited by truncated 
opportunities or historical circumstances.” Thus if low income households are less likely 
to seek care because of past adverse encounters with the health care system, their choices 
today may be related less to immutable preferences and more to past financial or cultural 
barriers in access to care.  
Another shortcoming of using health expenditures is that higher levels of 
expenditures may not translate into better health outcomes.  Glover (1938) counseled 
against the overuse of tonsillectomies at a time when the risk of surgical complications 
was high.  He and his colleagues noted that children of anxious high-income parents were 
more likely to receive the procedure and hence more likely exposed to the risk of   7 
operative mortality.  More generally, Fisher et. al. (2003a, b) has suggested that regions 
with greater use of health care were no more likely to experience better outcomes or even 
improved satisfaction of patients and access to care.  In other words, higher expenditures 
do not always translate into better health. 
In the past decade, there has been an increasing interest in the inequality of health, 
whether measured as lifespan, quality-adjusted life years, healthy life years, or self-
reported health.
8  Measuring health outcomes avoids the problem of inferring the 
effectiveness of health care expenditures on outcomes.  It also has the advantage of 
capturing income-based differences in a variety of factors such as health behavior, diet, 
and life-course events that have a larger impact on health outcomes than the health care 
system alone.  The results are if anything quite a bit stronger, exhibiting a uniform and 
consistent gradient between income and health care outcomes.  
Inequality in health outcomes can be present even in the absence of inequality in 
health care.  Suppose that the health care system were perfectly equal, and provided 
instant access to all people in society.  Inequality in outcomes could still occur for a 
variety of reasons.  The first is simply luck or genetic differences across the population 
(Gakidou, Murray, and Frenk, 2000).  However, most summary measures of income-
based health inequality remove this source of inequality by averaging over large numbers 
of individuals.  For example the “concentration index” compares the cumulative 
distribution of income on the horizontal axis, and the cumulative distribution of healthy 
                                                 
8  Berloffa, Brugiavini, and Rizzi, 2003; Case and Deaton, 2003; Contoyannis and Jones, 2004; 
Elstad and Krokstad, 2003; Gakidou, Murray, and Frenk, 2000; Glied and Lleras-Muney, 2003; 
Goldman and Smith, 2002; Preston and Taubman, 1994; Van Doorslaer, et. al., 1997; Wagstaff 
and van Doorslaer, 2004. 
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life years (however measured) on the vertical axis, thereby averaging out variation 
occurring within income categories.
9 
The second source of lifespan inequality arises from potential differences in 
health behavior such as diet, smoking, exercise, drinking, and other factors associated 
with income and socioeconomic status, so that “... inequalities in health reflect the wider 
inequalities in society.” (Le Grand, 1982, p. 45.) For example, Contoyannis and Jones 
(2004) report that these measures of “healthy living” in 1984 were strong predictors of 
positive good health in 1991.  Of course, this raises the very difficult question again of 
how one can separate “preferences” for health-related behavior from income per se.  
These health behaviors or health shocks can have long-lasting effects, for example see 
Almond’s (2003) study of the long-term negative repercussions of being in utero during 
the 1918 influenza epidemic.  As well, these long-term health shocks can affect both 
earnings capacity and health, muddying the causal link between income and health 
outcomes even further (Case and Deaton, 2003; Elstad and Krokstad, 2003; Graham, 
2002).    
We suggest a more restrictive but theoretically cleaner measure of health care 
inequality: to measure utilization rates of effective care, procedures that are efficacious 
for every appropriate patient.  Examples include mammography screening for women 
aged 65-69, and ￿ blocker, aspirin, reperfusion therapies, and ACE inhibitor use for heart 
attack patients.
10   Mammography has been adopted as a measure of preventive care in 
                                                 
9   The measure of inequality is then calculated much like the Gini coefficient; for a general 
discussion of health inequality decompositions, see Contoyannis and Forster (1999). 
 
10  Reperfusion therapy (12-hour angioplasty or “clot busting” thrombolytics) is effective at 
removing the blockage or clots restricting blood flow to the heart.  Aspirin is effective at breaking 
down platelets that are essential components of these clots interfering with blood flow.  ACE   9 
other studies as well, for example see Decker (2004) and Card, Dobkin, and Maestas 
(2004). 
There are several advantages in using such measures.  The first is the existence of 
a reliable link between utilization and health outcomes.  Second, there is no need to 
control (however imperfectly) for health status, since among appropriate or ideal patients, 
nearly everyone should receive the treatment.  Finally, preferences should generally not 
play a strong role in the use of such interventions, given that the objective benefits are so 
much larger than the costs.
11  Trends or levels in several of these effective care measures 
will be considered further below, after first examining the empirical record on the 
evolution of health care expenditures and survival by income group.   
2.  The Distribution of Medicare Expenditures by Zip Code Income 
  The Continuous Medicare History Survey (CMHS), a 5 percent sample of every 
Medicare enrollee, is used to consider the secular trends of overall Medicare expenditures 
by income decile.  Because individual income is not available in the Medicare claims 
data, we instead use median zip code income from the 1990 U.S. Census, assigned to 
each individual in the Medicare denominator file based on their mailing address zip code. 
(The results are not sensitive to the use of the 2000 Census income data.)  There are 
advantages and disadvantages of using zip code income from the Census instead of 
individual income data from surveys.  On the one hand, the neighborhood that a person 
                                                                                                                                                 
inhibitors attenuate the body’s natural tendency to constrict vascular walls, while ￿ blockers 
reduce the body’s demands on the heart. 
 
11 In practice, Walter et. al. (2004) has pointed out that preferences could play a legitimate role 
for some patients who may not want to be screened.  These arguments are harder to make in the 
case of heart attack treatments; it seems unlikely that anyone should prefer not to take aspirin 
following a heart attack.  Alternatively, one may view the benefits as being sufficiently high to 
justify paternalistic efforts on the part of the government to encourage such practices.     10 
lives in may better reflect permanent income than self-reported income, which may be 
infested with measurement error and transitory income, and particularly for the elderly 
population not reflect important components of household wealth.  On the other hand, zip 
code income is subject to “ecological bias,” poor Medicare enrollees in rich 
neighborhoods could be treated differently from rich enrollees in poor neighborhoods.  
One previous study, however, has suggested that zip code income provides a reasonable 
characterization in health-related research (Geronimus, et. al., 1996).    
In quantifying health care expenditures for the over 65 population, we express all 
expenditures in 2001 dollars, and estimate age-sex-specific expenditures in 5-year age 
increments (plus those 85+) for each of 10 income deciles.  In aggregated data, we use 
direct adjustment to normalize the per capital Medicare expenditures to a constant age 
and sex composition over time by use of the sample frequencies of the 10 age-sex 
categories.
12   Only fee-for-service Medicare enrollees are included in the sample, which 
means that expenditures made on behalf of enrollees in Medicare managed care will not 
be included in this sample.
13  The sample size is sufficiently large (30.8 million person-
years) that standard errors are small, and so are not reported. 
Table 1 and Figure 1 present expenditures for selected income deciles in 1987-
2001.  Not surprisingly, real Medicare expenditures have increased during this period.  
                                                 
12  Thus the age-sex frequencies are averages over 1987-2001.  Just the 80+ population is 
considered in quantifying home health care, and so for this group there are four age-sex 
categories, males 80-84, males 85+, females 80-84, and females 85+. 
      
13  Until 1997, managed care organizations were reimbursed for their Medicare enrollees by a 
capitated fee based on 95% of the lagged value of regional fee-for-service expenditures, so that 
fee-for-service expenditures within a region would have been a reasonable measure of the 
managed care capitation fee.  While the Balanced Budget Act of 1997 severed that close link, it is 
not expected that the relatively small fraction of Medicare managed care enrollees would bias 
these results. 
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However, the rates of growth by income group are quite different; the bottom decile 
experienced a 78 percent increase in real expenditures, in contrast to the top decile with 
just a 34 percent increase.   
The advantage of health care dollar expenditures is that these changes in spending 
can be compared to changes over the same period of time in median money income, as 
measured in the Current Population Survey.  The median increase in family income 
during the period 1987-2001 was $2551.
14  In 1993, the average household size of elderly 
people living either along or with a spouse was 1.47,
15  so the per capita increase in 
income per elderly person was $1735 = $2551/1.47.  Note that the dollar increase in 
expenditures for the lowest income decile was $2624, compared to $1214 for the highest 
income group.  Thus the size of the differential increase (or “twist”)  in Medicare 
expenditures was $1410 ($2624 minus $1214) or the amount of money that would have 
been left “on the table” had Medicare costs for the lowest income group grown at the 
same rate as the highest income group.  This differential increase is therefore 81 percent 
of the total increase in money income for the elderly population during 1987-2001.  It is 
also larger than the average level of per capita benefits from the Earned Income Tax 
Credit (EITC) program, estimated to be $1287 (in 2001 dollars) among the near-poor 
(Short and Garner, 2002).  Unlike the EITC, the redistribution occurring in the Medicare 
                                                 
14  In 2001 dollars, http://www.census.gov/hhes/income/histinc/f11.html. 
 
15 U.S. Census (1996) Page 6.6.  To estimate the average household size, we excluded people 65+ 
living with other relatives or with unrelated people, and assumed the spouse was also age 65+.  
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program was largely unintended, and the differential benefits to the lowest income group 
are still not well understood.
16   
  Why the differential growth in expenditures? One reason was the growth in the 
Disproportionate Share Hospitals (DSH) program that provided higher reimbursements 
for hospitals in low income neighborhoods (see Baicker and Staiger, 2004).  Another 
factor was the rapid expansion of home health care during the 1990s.  Beginning in the 
late 1980s, when restrictions on the use of home health care were eased, there were 
dramatic increases in the use of home health care particularly in certain regions of the 
U.S. such as Texas, Florida, and Tennessee (Wennberg and Cooper, 1999).  Because of 
the rapid growth in expenditures, and an accompanying increase in scandals, Congress 
restricted its use sharply in 1997.  These expenditures for home health care were 
concentrated to a large extent in the poorest zip codes of the U.S.
17  Figure 2 tabulates 
average home health care spending for the 80+ population (the most common users of 
home health care) by year for the lowest income Decile 1, Deciles 5, and the highest 
income Decile 10.  These are measures of spending per Medicare enrollee age 80 and 
older, and not restricted just to users of home health care.  There was rapid growth in 
home health care expenditures for all income groups, but the growth for Decile 1 was 
                                                 
16  One shortcoming with these changes in Medicare expenditures is that we do not have similar 
data on Medicaid expenditures.  In theory, a decline in Medicaid expenditures among the low 
income groups could have been offset by this sharp increase in Medicare expenditures, with no 
net impact on transfers to lower income neighborhoods.  However, Medicaid expenditure data by 
state and by year for home health care expenditures provides little support for this explanation.  
While Medicaid programs in New York were spending more on recipients than in Texas in 1991 
($623 versus $74), by 1997 the spending levels had not changed appreciably ($647 in New York, 
$146 in Texas).  Source: http://www.cms.hhs.gov/statistics/nhe/state-estimates-
residence/medicaid-per-capita50.asp 
 
17  See Lee, McClellan, and Skinner (1999). 
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particularly notable, rising to $1635 per elderly enrollee before dropping after 1997 when 
the Balanced Budget Act clamped down on unrestricted use. 
How much of this spending benefited low income patients, either through 
improved survival or improved quality of life?  In 1997, a report by the General 
Accounting Office suggested that 40% of all home health care costs were “inappropriate” 
(Havemann, 1997). In this case, inappropriate care included either fraud (e.g., a physician 
prescribing tests for sexually transmitted diseases to all of his home health care patients) 
or that the patient simply was not eligible for home health care.  A recent paper by Robin 
McKnight (2004) did not find adverse health consequences caused by the sharp decline in 
home health care benefits in 1997, although there was a modest consequent increase in 
out-of-pocket medical expenses.  In short, one should be cautious about attributing all 
dollar increases in Medicare expenditures to the people who nominally “receive” the 
benefit.
18  Home health care is not the only service provided during the 1990s that may 
have also benefited providers’ bank accounts, but it was certainly the most visible.
19 
3.  The Distribution of Survival Gains by Income 
  We next consider overall survival gains in the Medicare population.  Here the 
sample includes not just the fee-for-service population but also the HMO enrollees; this is 
to avoid potential selection bias caused by healthier individuals joining managed care 
                                                 
18  This is the basic insight of tax incidence studies, the tax burden does not necessarily fall on the 
people who pay the tax.  Similarly, government benefits do not necessarily flow to the people 
whose names are on the checks.    
 
19  Another cause for the rapid increase in health care expenditures during the 1990s was 
upcoding whereby hospitals switched patients from low-reimbursement to high-reimbursement 
diagnostic related groups (Silverman and Skinner, 2004) and effectively increased the price 
charged per Diagnostic-Related Group (DRG).  Upcoding, which is distinguishable from “bracket 
creep” by the absence of supporting evidence for the more expensive coding, was curtailed 
sharply also around 1997 following well-publicized investigations of a large for-profit hospital 
chain.    
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organizations. We consider two different cohorts from the Continuous Medicare History 
Survey.  The first is the group of people age 65-69 and 75-79 alive in 1982, and the 
second is the corresponding group alive at age 1992.  Figure 3 shows the percentage of 
the groups age 65-69 in the initial year who were still alive ten years later by sex and year 
of the cohort by income decile.  There is a clear income gradient in both years; people 
living in higher zip code incomes were more likely to survive during both the 1980s and 
1990s.  A similar pattern is shown for those aged 75-79 in 1982 and 1992, detailed in 
Table 2, with life expectancy rising by more for men than for women.  While all groups 
gained in terms of survival probabilities, the highest income groups gained the most, both 
in percentage and in absolute terms.  
To quantify these changes in terms of the change in expected survival years, we 
chain together the two panels of 10 year survival curves for the younger and older 
cohorts, and estimate the change in expected survival years for a synthetic cohort over a 
20 year period (from 65-69 to 85-89) with fixed weights for men and women based on 
the fraction of women in the age 65-69 cohort (54.8 percent).  There was a 0.2 increase in 
expected life years in the bottom income decile, a 0.5 increase in the 5th decile, and a 0.8 
increase in the top income decile.
20   
4.  Inequality in the Provision of Effective Care  
Here we focus on specific measures of effective care, considering first mammography 
rates among women age 65-69 in the Medicare population.  The advantage of using 
                                                 
20 Recent work has focused on placing a dollar value to increased survival, see Becker, Philipson, 
and Soares (2003) or Berloffa, Brugiavini, and Rizzi (2003).  A different approach to quantifying 
the changes over time in survival is the concentration index, a variant of a Gini coefficient 
(Contoyannis and Forster, 1999).  However, changes in the index were very small since we were 
just considering inequality in the over 65 population and not over the entire life-course.   
   15 
mammography rates is that we have a time-series on rates of screening from 1993-2001 
and so can measure changes over time in screening rates.  A 5% sample of Part B 
physician claims data is used from 1993-1997, and a 20% sample from 1998-2001.  The 
later 20% sample also includes hospital outpatient data as separate from physician-based 
claims, these would include women who were screened for example in a hospital-based 
clinic. In theory, not including such outpatient records for all years could bias our results 
if low income women were more likely to receive care in an outpatient setting.  In 
practice, as we show using data from 1998-2001, the bias is small or non-existent.  
Figure 4 shows rates of screening by year for selected income deciles for just the 
physician claims, these are comparable over time.  Reported in brackets during 1998-
2001 are rates that include the outpatient screening data; while raising all rates the 
relative magnitudes by income group are largely unchanged.   
There is a pronounced income gradient in screening rates that persists throughout 
the period of analysis.  In 1993, the range in screening rates (between Decile 1 and Decile 
10) was 16 percentage points, while in 2001, the range had shrunk slightly to 15 
percentage points.  A notable feature of the data is the sharp jump in rates between 1997 
and 1998.  This was the consequence of removing the $100 coinsurance payment on 
January 1, 1998 and allowing reimbursement for annual rather than biannual screening.  
It is surprising that rates for all income groups appear to have risen by about the same 
amount, given that low income households should have been most sensitive to the 
relaxation of the $100 copayment.    
Similar results for 1998-2001 were also found in comparing rates of screening for 
eye examinations among patients with diabetics.  These examinations check for damage   16 
to the vascular system caused by high uncontrolled blood glucose levels (available upon 
request from the authors).  While encompassing a shorter time period, there was similarly 
no evidence of trends in the income-based gradient of screening for diabetic eye 
examinations.   
Of course, some part of the income-based differential could be the consequence of 
noncompliance; that is that lower income patients don’t sign up or show up for their 
screening appointment.  We therefore consider physician directives or procedures 
performed in the first few days following acute myocardial infarction, where the primary 
goal of the physician is to keep the patient alive, and patient preferences and 
noncompliance issues should play a small role. The measures of effective care for heart 
attack patients are derived from the Cooperative Cardiovascular Project (CCP) survey of 
more than 160,000 AMI patients over age 65 in 1994/95.  The survey information 
included detailed clinical data from chart reviews along with information on how the 
patient was treated.  This allowed clinical researchers to determine from the chart data 
patients who were “ideal” or appropriate for the use of the specific treatment; thus the 
right rate should be a number near 100 percent, regardless of health status, income, age, 
or any other characteristic.  For this reason, we do not control for covariates or health 
indices, but consider simple averages by income decile.  
  Table 4 presents income-based differences in utilization of effective care along 
with the total sample size in the bottom row.  Approximate 95% confidence intervals are 
presented at the bottom of the table; these apply to each of the means in the column 
because the deciles ensure equal sample sizes and the exact binomial confidence intervals 
are based on the average ratio.     17 
Table 4 suggests that in 1994/95, utilization of these measures were remarkably 
low.  For example, the use of ￿ Blockers was less than half of appropriate patients when 
the target rates should have been closer to 100 percent.   Second, rates of use for effective 
care were modestly elevated among higher income groups; for example in ￿ Blockers, 
rates ranged from 40 percent in the bottom income decile to 47 percent in the top decile.  
Indeed, for some treatments, such as ACE inhibitors used to control hypertension, there 
were no income-based difference in utilization.  
One additional question is whether high income individuals are more likely to 
receive higher quality care because of treatment differences within regions, or because 
they are more likely to live in regions where overall effective care rates are higher 
(Chandra and Skinner, 2003).  In Figure 5 utilization rates for ￿ Blockers are estimated 
with and without categorical regional variables.  First, the previous results are replicated 
in a logistics regression coefficients converted to percentage screening rates.  State 
dummy variables are then introduced and the logistics regression is re-estimated, again 
with odds ratios converted to probabilities, and shown in Figure 5.  The adjusted 
probability of ￿ Blocker use holding constant the state of residence shows just a 3.6 
percentage point difference by income group rather than a 7 percentage point difference.  
(In this latter regression, only the 8
th and 10
th decile coefficients were significantly 
different from zero.)  That is, half of the income gradient here is the consequence of 
where patients live and not how patients are treated within regions.   The result does not 
generalize, however.  A similar analysis for mammography screening and diabetic eye   18 
exams during 1998-2001 did not suggest any diminution in the effects of income on 
utilization rates after controlling for region of residence.
21  
In theory, we would like to know how the income gradient in ￿ Blocker use 
evolved over time, but we have just one observation from the survey in 1994/95.  Since 
the use of ￿ Blockers for heart attack patients were rare before the early 1980s, we may 
safely infer that the observed difference in 1994/95 reflects a somewhat higher growth 
rate in the use of ￿ Blockers among the top income deciles, at least through 1994/95.  
Since then, compliance has improved, but in 2001 median compliance is still less than 70 
percent (Jencks, 2003).  It is possible that rates of compliance have risen more rapidly in 
low income regions, but Alabama was low in the use of ￿ Blockers in 1994/95 and it 
remained relatively low in 2001.  
5. Conclusions and Discussion 
How should one judge whether inequality in health has improved or worsened 
during the past several decades?   This paper has considered several alternative 
approaches to measuring inequality using US data from the elderly Medicare population 
over age 65.  While Medicare expenditures grew much more rapidly among the lowest 
income deciles, health outcomes improved much less rapidly for this group.  Economists 
and health services researchers have long recognized the distinction between inequality in 
health care (as measured by expenditures) and inequality in health (as measured by 
survival), beginning at least with Victor Fuchs’ comparison of Nevada and Utah, two 
                                                 
21  In this case, because the sample sizes were so much larger, we were able to use the 306 
hospital referral regions (Wennberg and Cooper, 1999) as regional controls instead of states as in 
the analysis of ￿ blockers.  
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states with similar health care expenditures but very different mortality rates (Fuchs, 
1998b).   
We suggest a different approach to measuring inequality that relies on effective 
care, or measures of health care quality.  For these measures, efficacy is well proven and 
nearly all of the relevant population should be receiving it, regardless of health status or 
preferences.   A examination of the past decade suggests that there has been little or no 
relative improvement in the utilization of effective care measures among lower income 
deciles.  Thus the discordance between rapidly rising health expenditures of low income 
households and rapidly rising longevity of high income households is not quite so 
puzzling.  
  It should be cautioned that the magnitudes of the differences in effective care 
observed in the data would not be expected to exert a large impact on overall mortality 
rates.  The predicted impact on heart attack patients of a 7 percentage point increase in ￿ 
blocker use (i.e., the difference between the top and bottom income decile rate of use) is a 
0.21 percentage point decline in mortality, or an overall impact on the general population 
of about 0.01 percent since just 5 percent of the Medicare population experience a heart 
attack in any year.
22  The fact that these measures of effective care account for a small 
fraction of overall expenditures, and a small fraction of the overall variation in health 
outcomes, motivates interest in other measures of quality, for example with regard to the 
overuse of marginally effective procedures (Fisher, et. al., 2003a,b). 
                                                 
22   The 0.21 percent shift is derived by multiplying 7 percentage points times the implied 3 
percentage point reduction in one-year mortality estimated by using an odds ratio (estimated for 
30 day mortality) of 0.88 reported in Heidenrich and McClellan (2001).   
   20 
There are three important limitation of this study.  The first is that in using 
outcome data, we have focused only on survival and not quality-adjusted or “healthy life 
years.”  To capture a more full measure of health, it would be necessary to include 
income-based differentials in treatments with proven effectiveness but for improving 
functioning rather than survival per se.  Examples include hip or knee replacements for 
the treatment of osteoarthritis or the use of angioplasty for patients with ischemic heart 
disease.  However, measuring true income-based differences in health status is more 
difficult, given the necessity of adjusting for differential health needs (i.e., rates of 
osteoarthritis of the hip by income group) and for preferences (however defined) 
regarding surgical intervention.
23  
Second, the study is limited to just the over-65 population. Focusing just on 
income-based differences in mammography rates within the Medicare program ignores 
the fact that Medicare itself contributes to a substantial increase in mammography rates at 
age 65 among those previously uncovered by insurance or in lower educational groups 
(Decker, 2004; Card, Dobkin, and Maestas, 2004).  Focusing just on inequality within a 
specific age group ignores changes in inequality across age groups, for example 
differences between those under age 65 who are increasingly lacking health insurance, 
and those over age 65 who are generally covered (Danziger, Haveman, and Smolensky, 
1977).   
Finally, we have not considered the financing side of the Medicare program.  
During the 1990s payments both rose and became more progressive as general income 
taxes became a larger source of revenue (McClellan and Skinner, 2004).  The new 
                                                 
23  Chen and Escarce (2004) for example attempt to control for income-based differences in health 
status along a wide variety of dimensions.   21 
prescription drug benefits passed into law in 2003 should also contribute to an increasing 
degree of redistribution to the extent the future growth in benefits are financed out of 
general tax revenue.  Whether increased progressivity in the Medicare program would 
justify the increased longevity of higher income households is not entirely clear, 
however. 
A singular advantage of focusing on equality in effective care (or quality of care) 
is that there are reasonable approaches to fixing the problem.   Monitoring claims data in 
real time with the objective of raising rates to ideal levels of near 100% among 
appropriate candidates is one sure way to at least reduce income-based inequality in 
health outcomes.  Inequality in outcomes would continue to persist for many years, of 
course, but at least such differences would not be exacerbated by inequality in health 
care.  Indeed, one could imagine “non-discrimination” rules like those developed for 
401(k) pension plans in which hospitals or health care systems would experience a partial 
loss in Medicare funding if effective care measures for their low income patients fell too 
far below those for their high income patients.    22 
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Table 1: Medicare Expenditures by Year and Zip Code Income Decile 
 
 
  Decile 1  Decile 3  Decile 5  Decile 8  Decile 10 
1987  3346  3159  3228  3478  3588 
1988  3548  3309  3343  3556  3656 
1989  3926  3619  3590  3817  3980 
1990  4068  3637  3698  3904  3970 
1991  4265  3852  3811  4050  4022 
1992  4457  4039  3914  4119  4123 
1993  4740  4140  4102  4199  4219 
1994  5365  4553  4465  4432  4464 
1995  5743  4736  4702  4605  4611 
1996  5998  4931  4804  4596  4675 
1997  6120  5073  4778  4651  4666 
1998  6337  5311  5031  4804  4908 
1999  6153  5299  5002  4719  4946 
2000  5895  5068  4885  4614  4725 
2001  5970  5080  4873  4574  4802 
Dollar Change, 
1987-2001  2624  1921  1645  1096  1214 
Percentage Change, 
1987-2001  78.4  60.8  51.0  31.5  33.8 
Source: Medicare Continuous History Survey.  Controls for age and sex.  All 
expenditures expressed in $2001.  
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Table 2: 10-Year Survival Probabilities 
 By Age and Sex: 1982-91 and 1992-2001 
 








Age 65-69  Age 75-79  Income 
Decile  82-91  92-01  82-91  92-01  82-91  92-01  82-91  92-01 
1  59.0  61.9  75.8  75.4  34.6  35.1  51.2  51.8 
2  61.5  64.3  77.5  77.4  35.3  36.5  53.3  53.1 
3  62.0  66.0  77.8  78.7  35.0  37.6  53.6  54.1 
4  63.2  67.2  79.2  79.2  34.8  37.6  53.8  55.0 
5  64.1  68.2  77.9  79.4  36.0  39.7  53.9  55.1 
6  64.5  68.9  78.8  79.8  36.1  39.8  53.9  54.8 
7  64.6  69.7  79.0  80.4  35.4  39.9  53.8  55.7 
8  65.8  70.9  79.4  80.7  37.3  41.0  54.1  56.2 
9  66.5  72.5  79.8  81.8  38.2  42.9  54.1  56.3 
10  69.2  74.8  81.1  83.4  38.7  44.8  54.7  57.1 
Sample  188,177  217,272  229,308  263,093  98,053  126,011  152,606  187,554 
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Table 3: Mammography Rates by Year and Zip Code Income Decile 
For Women Age 65-69 
 
 
  Decile 1  Decile 3  Decile 5  Decile 8  Decile 10 
1993  20.7  25.9  28.2  30.6  34.6 
1994  22.8  28.3  30.1  32.2  35.7 
1995  24.0  30.1  31.7  33.0  36.8 
1996  23.8  29.0  30.0  32.4  36.1 
1997  24.7  29.3  31.6  33.3  37.1 









































1993-2001  15.8  18.1  17.0  16.4  14.8 
Change: 
1997-2001   11.7  14.7  13.7  13.7  12.3 
Source: Medicare Part B Claims Data only.  Figures in brackets are 
both Medicare Part B plus outpatient claims.   
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Table 4: Rates of Effective Care for Acute Myocardial Infarction 

















1  40  57  32  33 
2  39  57  32  35 
3  43  60  33  34 
4  45  59  33  35 
5  45  59  34  37 
6  44  57  35  34 
7  45  59  37  34 
8  47  59  37  37 
9  45  59  36  35 




±1.4  ±2.2  ±1.7  ±2.3 
Sample size  50,156  19,286  32,097  17,151 
Source: Cooperative Cardiovascular Project.   
*      Universe: appropriate (beta blocker) or eligible (for reperfusion).  
**    Universe: ideal patients 
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Figure 3: 10-Year Survival Rates For Age 65-69 Cohorts 
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Note: Rates per Females Age 65-69.  The 100 dollar coinsurance rate was removed on 1 




Figure 5: Estimates of the Income Gradient for the Use of ￿ Blockers for 
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